Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1958 1
1960 1
1961 5
1962 1
1963 2
1968 1
1970 1
1972 1
1975 1
1976 2
1977 1
1979 1
1981 1
1982 1
1983 3
1984 1
1985 6
1986 2
1987 1
1988 2
1989 1
1990 2
1991 2
1992 2
1993 4
1994 2
1995 3
1996 3
1997 2
1999 2
2000 1
2002 1
2003 1
2004 2
2005 4
2006 2
2007 4
2008 7
2009 5
2010 1
2011 8
2012 5
2013 6
2014 6
2015 11
2016 7
2017 3
2018 2
2019 4
2020 6
2021 5
2022 7
2023 11
2024 10
2025 10

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

178 results

Results by year

Filters applied: . Clear all
Page 1
Neurofilament light-chain response during therapy with antisense oligonucleotide tofersen in SOD1-related ALS: Treatment experience in clinical practice.
Meyer T, Schumann P, Weydt P, Petri S, Koc Y, Spittel S, Bernsen S, Günther R, Weishaupt JH, Dreger M, Kolzarek F, Kettemann D, Norden J, Boentert M, Vidovic M, Meisel C, Münch C, Maier A, Körtvélyessy P. Meyer T, et al. Among authors: vidovic m. Muscle Nerve. 2023 Jun;67(6):515-521. doi: 10.1002/mus.27818. Epub 2023 Apr 3. Muscle Nerve. 2023. PMID: 36928619
Clinical and patient-reported outcomes and neurofilament response during tofersen treatment in SOD1-related ALS-A multicenter observational study over 18 months.
Meyer T, Schumann P, Weydt P, Petri S, Weishaupt JH, Weyen U, Koch JC, Günther R, Regensburger M, Boentert M, Wiesenfarth M, Koc Y, Kolzarek F, Kettemann D, Norden J, Bernsen S, Elmas Z, Conrad J, Valkadinov I, Vidovic M, Dorst J, Ludolph AC, Hesebeck-Brinckmann J, Spittel S, Münch C, Maier A, Körtvélyessy P. Meyer T, et al. Among authors: vidovic m. Muscle Nerve. 2024 Sep;70(3):333-345. doi: 10.1002/mus.28182. Epub 2024 Jun 20. Muscle Nerve. 2024. PMID: 39031772
Effects of tofersen treatment in patients with SOD1-ALS in a "real-world" setting - a 12-month multicenter cohort study from the German early access program.
Wiesenfarth M, Dorst J, Brenner D, Elmas Z, Parlak Ö, Uzelac Z, Kandler K, Mayer K, Weiland U, Herrmann C, Schuster J, Freischmidt A, Müller K, Siebert R, Bachhuber F, Simak T, Günther K, Fröhlich E, Knehr A, Regensburger M, German A, Petri S, Grosskreutz J, Klopstock T, Reilich P, Schöberl F, Hagenacker T, Weyen U, Günther R, Vidovic M, Jentsch M, Haarmeier T, Weydt P, Valkadinov I, Hesebeck-Brinckmann J, Conrad J, Weishaupt JH, Schumann P, Körtvélyessy P, Meyer T, Ruf WP, Witzel S, Senel M, Tumani H, Ludolph AC. Wiesenfarth M, et al. Among authors: vidovic m. EClinicalMedicine. 2024 Feb 15;69:102495. doi: 10.1016/j.eclinm.2024.102495. eCollection 2024 Mar. EClinicalMedicine. 2024. PMID: 38384337 Free PMC article.
A randomized double-blind clinical trial on safety and efficacy of tauroursodeoxycholic acid (TUDCA) as add-on treatment in patients affected by amyotrophic lateral sclerosis (ALS): the statistical analysis plan of TUDCA-ALS trial.
Lombardo FL, Spila Alegiani S, Mayer F, Cipriani M, Lo Giudice M, Ludolph AC, McDermott CJ, Corcia P, Van Damme P, Van den Berg LH, Hardiman O, Nicolini G, Vanacore N, Dickie B, Albanese A, Puopolo M; TUDCA-ALS Study Group. Lombardo FL, et al. Trials. 2023 Dec 5;24(1):792. doi: 10.1186/s13063-023-07638-w. Trials. 2023. PMID: 38053196 Free PMC article. Clinical Trial.
Sleep Disorders in Acute Stroke.
Kojic B, Dostovic Z, Vidovic M, Ibrahimagic OC, Hodzic R, Iljazovic A. Kojic B, et al. Among authors: vidovic m. Mater Sociomed. 2022 Mar;34(1):14-24. doi: 10.5455/msm.2022.33.14-24. Mater Sociomed. 2022. PMID: 35801067 Free PMC article.
Post-stroke language disorders.
Sinanović O, Mrkonjić Z, Zukić S, Vidović M, Imamović K. Sinanović O, et al. Among authors: vidovic m. Acta Clin Croat. 2011 Mar;50(1):79-94. Acta Clin Croat. 2011. PMID: 22034787 Review.
Targeted Proteomics upon Treatment with Tofersen Identifies Novel Response Markers for Superoxide Dismutase 1-Linked Amyotrophic Lateral Sclerosis.
Steffke C, Baskar K, Bachhuber F, Wiesenfarth M, Dorst J, Schuster J, Schöberl F, Reilich P, Regensburger M, German A, Günther R, Vidovic M, Petri S, Meyer T, Hagenacker T, Grosskreutz J, Weyen U, Weydt P, Haarmeier T, Lingor P, Wolf J, Hermann A, Prudlo J, Günther K, Knehr A, Elmas Z, Uzelac Z, Witzel S, Ruf WP, Freischmidt A, Ho R, Ludolph AC, Weishaupt JH, Tumani H, Oeckl P, Brenner D, Catanese A. Steffke C, et al. Among authors: vidovic m. Ann Neurol. 2025 Aug 9. doi: 10.1002/ana.70025. Online ahead of print. Ann Neurol. 2025. PMID: 40781905
178 results